Company

Trace Neuroscience, Inc.

Trace Neuroscience develops genomic medicines for neurodegenerative conditions.

About

Trace Neuroscience develops genomic medicine for neurodegenerative conditions. Founded in 2024, it is based in California, US, and was led by CEO Eric Green as of November 2024. It raised USD 101 million in Series A funding in November 2024, led by Third Rock Ventures with Atlas Venture, GV, and RA Capital Management participating.

2Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in